Verve Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
VERV
CUSIP
92539P101
Type
Equity
Class
COM
Num filers
177
Total reported value, excl. options
$819M
Manager Report Date Value ($000) Shares